GlaxoSmithKline (GSK) Pharma and Biotech Sector

  • Latest quote

    1,302.50p (mid)

  • Current Change (%)

    0.12%

  • Price

    Bid: 1,304.50p

    Offer: 1,305.00p

  • Today

    High: 1,316.00p

    Low: 1,295.50p

  • This year

    High: 1,722.00p

    Low: 1,295.50p

  • Information

    Volume: 6,938,099

    Market Cap: £64179.9M


GlaxoSmithKline RNS Feed

Title Release date
ViiV Juluca approved in US as first 2-drug regimen 07:00 - November 22, 2017
GSK publishes 2018 dividend dates 14:21 - November 21, 2017
Trelegy Ellipta EU approval for treatment of COPD 07:00 - November 16, 2017
Director/PDMR Shareholding 13:15 - November 10, 2017
Block listing Interim Review 17:00 - November 9, 2017
Directorate Change 14:00 - November 8, 2017
Directorate Change 14:00 - November 8, 2017
US regulatory application for mepolizumab in COPD 15:01 - November 7, 2017
BCMA receives FDA Breakthrough Therapy Designation 07:35 - November 2, 2017
Total Voting Rights 12:01 - November 1, 2017
Superiority of Anoro Ellipta demonstrated for COPD 11:01 - November 1, 2017
CDC ACIP makes recommendations for use of Shingrix 17:46 - October 25, 2017
Director/PDMR Shareholding 15:21 - October 25, 2017
3rd Quarter Results 12:00 - October 25, 2017
GSK's Shingrix Receives US FDA Approval 07:00 - October 23, 2017

NOTE: This is based on 325 open tips for this company


Total Number of Share tips :

325

View all GlaxoSmithKline Tips


Company overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today